The hospital had stopped its lung transplant program in May due to the departure of its primary lung transplant surgeon and had stopped its heart transplant program in July due to low patient volume, according to a Philadelphia Inquirer report.
The recruitment of T. Sloane Guy, MD, as chief of cardiothoracic surgery and Yoshiya Toyoda, MD, as director of heart and lung transplantation and mechanical circulatory support have provided the leadership needed to restart the programs, according to the release.
Related Articles on Hospital Transplant Programs:
2 Patients Test Positive for Hepatitis C Following Organ Transplantation
HHS Proposes Rules to Add Face, Hand Transplants to National Organ Network
Saint Thomas Hospital in Nashville Halts Heart Transplants
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
